Rory Martin, PhD
Senior Principal, Market Access Center of Excellence
IQVIA
Rory Martin specializes in applying real-world data to healthcare analytics and health policy analysis. His recent work has focused on the financial impact of rebate models used in the 340B program and the effectuation of maximum fair price in Medicare Part D. He has been an invited speaker at the FDA’s Center for Drug Evaluation and Research (CDER).
Sessions
-
24-Jun-202623BCMoment of Truth: 340 B at a Crossroad
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}